Scheme Profile

Mirae Asset Healthcare Fund - Regular (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
2,236
Inception Date
02-07-2018
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 31.559 (06-May-2024) / 20.672 (22-May-2023)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 31.18 ( -0.01) ( -0.04 %)
  • Benchmark
  • S&P BSE Healthcare TRI
  • Fund Manager
  • Vrijesh Kasera
  • Value of () 1,00,000 since inception
  • 3,11,840
  • Entry Load
  • NIL
  • Exit Load
  • 15% of the units allotted (including Switch-in/STP - in on or before completion of 365 days from the date of allotment of units: Nil. 1.00% - If redeemed within 1 year (365 days) from the date of allotment. Nil - If redeemed after 1 Year (365 days) from the date of allotment.
  • Expense Ratio (%)
  • 2.46
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 53.88 times
  • Portfolio P/B
  • 6.67 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.30

Risk Factors

  • Jenson's Alpha
  • 0.29
  • Standard Deviation
  • 4.44
  • Beta
  • 0.94
  • Sharpe
  • 0.74
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.38

NAV Movement

AUM Growth ( Cr.)

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • S&P BSE Healthcare TRI
  • 12.77
  • 0.00
  • 20.76
  • 56.63
  • 14.63
  • 22.60
  • 14.33
  • -

Company Top 5 Holdings

  [ As on 30 Apr 2024 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceuticals Industries Ltd
  • Equity
  • 20,58,051
  • 13.83
  • Cipla Ltd
  • Equity
  • 15,41,827
  • 9.65
  • Aurobindo Pharma Ltd
  • Equity
  • 17,98,059
  • 9.28
  • Dr Reddys Laboratories Ltd
  • Equity
  • 2,60,346
  • 7.22
  • Apollo Hospitals Enterprise Ltd
  • Equity
  • 2,26,399
  • 6.02

Sector Top 5 Holdings

  [ As on 30 Apr 2024 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 1,20,63,740
  • 79.77
  • Healthcare
  • 33,09,157
  • 17.64
  • Finance
  • 3,01,231
  • 1.37
  • Chemicals
  • 2,03,631
  • 1.23

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 9.42 10.92 12.77 2.40 2,236.01
2023 34.45 31.12 38.35 18.10 2,035.25
2022 -11.94 -9.58 -11.31 2.80 1,631.86
2021 25.76 17.96 20.57 21.69 1,935.10
2020 73.37 65.84 62.19 15.60 1,209.93
2019 6.24 4.22 -3.06 13.79 366.91
2018 2.65 -2.00 -5.45 6.67 314.94

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Mar-2024 9.26 9.70 10.84 1.91 2,235.15
Dec-2023 9.71 11.42 11.01 10.27 2,035.25
Sep-2023 13.13 11.39 11.65 0.96 1,862.72
Jun-2023 15.74 15.61 17.79 9.49 1,683.63

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Close